- Home
- AXDX vs BLAC Comparison
AXDX vs BLAC Comparison
Compare AXDX & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- BLAC
- Stock Information
- Founded
- AXDX 1982
- BLAC 2020
- Country
- AXDX United States
- BLAC United States
- Employees
- AXDX N/A
- BLAC N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- BLAC
- Sector
- AXDX Industrials
- BLAC
- Exchange
- AXDX Nasdaq
- BLAC NYSE
- Market Cap
- AXDX 28.3M
- BLAC 26.3M
- IPO Year
- AXDX 1996
- BLAC 2023
- Fundamental
- Price
- AXDX $1.19
- BLAC N/A
- Analyst Decision
- AXDX Hold
- BLAC
- Analyst Count
- AXDX 1
- BLAC 0
- Target Price
- AXDX $1.00
- BLAC N/A
- AVG Volume (30 Days)
- AXDX 31.2K
- BLAC 32.0K
- Earning Date
- AXDX 03-27-2025
- BLAC 01-01-0001
- Dividend Yield
- AXDX N/A
- BLAC N/A
- EPS Growth
- AXDX N/A
- BLAC N/A
- EPS
- AXDX N/A
- BLAC N/A
- Revenue
- AXDX $11,909,000.00
- BLAC N/A
- Revenue This Year
- AXDX $0.66
- BLAC N/A
- Revenue Next Year
- AXDX $3.36
- BLAC N/A
- P/E Ratio
- AXDX N/A
- BLAC N/A
- Revenue Growth
- AXDX N/A
- BLAC N/A
- 52 Week Low
- AXDX $0.73
- BLAC $3.01
- 52 Week High
- AXDX $2.09
- BLAC $13.40
- Technical
- Relative Strength Index (RSI)
- AXDX 46.90
- BLAC 9.80
- Support Level
- AXDX $1.07
- BLAC $5.61
- Resistance Level
- AXDX $1.22
- BLAC $7.18
- Average True Range (ATR)
- AXDX 0.10
- BLAC 0.72
- MACD
- AXDX -0.01
- BLAC -1.22
- Stochastic Oscillator
- AXDX 41.38
- BLAC 0.00
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About BLAC BELLEVUE LIFE SCIENCES ACQ CORP
Bellevue Life Sciences Acquisition Corp is a blank check company.